FDA RegulationVaccine DevelopmentmRNA Technology
Feb 19, 2026FDA Reverses Decision About Moderna Flu Vaccine
The FDA made an unprecedented reversal on its refusal to review Moderna's mRNA flu vaccine application, signaling significant political interference and creating regulatory uncertainty for the pharmaceutical industry.
